Research IPOs and Discover New Stocks
Four biotech IPOs launched this week. Two priced and began trading, and the other two are coming in the week ahead.
Our analyst team wasn’t high on either of this past week's deals, with peers trading poorly. Autoimmune-focused TRex Bio (Nasdaq: TRXB) became the
... read more
International IPO Index: International markets continued to back pedal this week. The International IPO Index declined -1.8%, while the ACWX ex-US ETF shed -0.7%. Hong Kong-listed condiment maker Foshan Haitian was the top performer, up +7.7%, while ... read more
While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two more on the calendar for the week ahead. RNA interference biotech City Therapeutics (CTY) plans to raise $175 million at a $1.0 billion...read more
Track the top IPOs from the past 3 years by market cap.
| Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|
| City Therapeutics | CTY | Get date on IPO Pro | 9.7 | $17.00 - $19.00 | $175 | Goldman Jefferies |
| Iambic Therapeutics | IAM | Get date on IPO Pro | 9.4 | $15.00 - $17.00 | $150 | JP Morgan Jefferies |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals | RTSN | 10/08/26 | $45 | $11.32 |
$+0.79
(7.5%)
|
-5.7% |
| TRex Bio | TRXB | 10/08/26 | $117 | $14.03 |
$+0.03
(0.2%)
|
0.2% |
| Accelevation | ACCV | 09/29/26 | $540 | $15.71 |
$-1.01
(-6.0%)
|
-12.7% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Preview
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
